Merck says FDA again declines to approve Bridion, needs more data
April 28, 2015 at 09:25 AM EDT
April 28 (Reuters) - Merck & Co on Tuesday said the U.S. Food and Drug Administration has again declined to approve Bridion, its drug to reverse the effects of muscle relaxants used in surgery, until the agency receives more data on allergic reactions to the product.